Key result
Viral 2A sequence in rAAV enables simultaneous vgf and eGFP overexpression in rodents at 32 weeks.
Why the study?
The viral 2A sequence offers a smaller alternative to IRES for simultaneous over-expression of two genes, but its long-term in vivo use with rAAV for gene and fluorescent marker co-expression required development and validation.
Answers are grounded in this paper and cite their sources.
The viral 2A sequence in an AAV plasmid allows for long-term, simultaneous over-expression of the vgf gene and a fluorescent tracking marker in vivo without compromising viral capacity.
INTRODUCTION: The viral 2A sequence has become an attractive alternative to the traditional internal ribosomal entry site (IRES) for simultaneous over-expression of two genes and in combination with recombinant adeno-associated viruses (rAAV) has been used to manipulate gene expression in vitro. NEW METHOD: To develop a rAAV construct in combination with the viral 2A sequence to allow long-term over-expression of the vgf gene and fluorescent marker gene for tracking of the transfected neurones in vivo. RESULTS: Transient transfection of the AAV plasmid containing the vgf gene, viral 2A sequence and eGFP into SH-SY5Y cells resulted in eGFP fluorescence comparable to a commercially available reporter construct. This increase in fluorescent cells was accompanied by an increase in VGF mRNA expression. Infusion of the rAAV vector containing the vgf gene, viral 2A sequence and eGFP resulted in eGFP fluorescence in the hypothalamus of both mice and Siberian hamsters, 32 weeks post infusion. In situ hybridisation confirmed that the location of VGF mRNA expression in the hypothalamus corresponded to the eGFP pattern of fluorescence. COMPARISON WITH OLD METHOD: The viral 2A sequence is much smaller than the traditional IRES and therefore allowed over-expression of the vgf gene with fluorescent tracking without compromising viral capacity. CONCLUSION: The use of the viral 2A sequence in the AAV plasmid allowed the simultaneous expression of both genes in vitro. When used in combination with rAAV it resulted in long-term over-expression of both genes at equivalent locations in the hypothalamus of both Siberian hamsters and mice, without any adverse effects.
No takes yet. Share an insight, caveat, or question.
Lewis et al. (2015) studied this question. rAAV construct with viral 2A sequence, vgf gene, and eGFP vs. commercially available reporter construct (in vitro) was evaluated on eGFP fluorescence and VGF mRNA expression. The use of a viral 2A sequence in an rAAV vector allowed simultaneous, long-term over-expression of the vgf gene and eGFP in the hypothalamus of mice and Siberian hamsters at 32 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: